Loading...
Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure
IMPORTANCE: In 2015, the US Food and Drug Administration approved 2 new medications for treatment of heart failure with reduced ejection fraction, sacubitril/valsartan and ivabradine. However, few national data are available examining their contemporary use and associated costs. OBJECTIVE: To evalua...
Na minha lista:
| Udgivet i: | JAMA Cardiol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Association
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6865331/ https://ncbi.nlm.nih.gov/pubmed/31738371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2019.4982 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|